Skip to Content
Merck

Skip To

T4580

Tiludronate disodium salt hydrate

≥98% (HPLC)

Promotion Available

Synonym(s):

Skelid, Tiludronic acid disodium, [[(4-Chlorophenyl)thio]methylene]bisphosphonic acid disodium salt hydrate

Sign In to View Organizational & Contract Pricing.

Spend ₪1,600 — Save 5%; Spend ₪2,500 — Save 10%; Spend ₪4,250 — Save 15%*

Sign in to check eligibility. Shop Products

Select a Size

Change View
Size/SKUAvailabilityPrice
10 mg
Please contact Customer Service for Availability
₪454.00

About This Item

Empirical Formula (Hill Notation):
C7H7ClNa2O6P2S · xH2O
CAS Number:
Molecular Weight:
362.57 (anhydrous basis)
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated

₪454.00

Save Up To 15%


Please contact Customer Service for Availability

​
Request a Custom Order
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Segment

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

color

white to off-white

solubility

H2O: >10 mg/mL, clear

originator

Sanofi Aventis

SMILES string

O.[Na+].[Na+].OP([O-])(=O)C(Sc1ccc(Cl)cc1)P(O)([O-])=O

InChI

1S/C7H9ClO6P2S.2Na.H2O/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14;;;/h1-4,7H,(H2,9,10,11)(H2,12,13,14);;;1H2/q;2*+1;/p-2

InChI key

SZVJRJRMQCKFON-UHFFFAOYSA-L

Biochem/physiol Actions

Tiludronate is a bisphosphonate bone resorption inhibitor. Tiludronate inhibits protein-tyrosine-phosphatase, leading to detachment of osteoclasts from the bone surface. It also inhibits the osteoclastic proton pump and is used to treat Paget′s disease.

Features and Benefits

This compound was developed by Sanofi Aventis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Preparation Note

Tiludronate disodium salt hydrate is soluble in DMSO at a concentration that is greater than or equal to 10 mg/ml.

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
N183A9232S4797
description

≥98% (HPLC)

description

≥98% (HPLC)

description

≥98% (HPLC)

description

BioXtra, ≥99.0%

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥98% (HPLC)

assay

≥99.0%

form

powder

form

lyophilized powder

form

powder

form

powder or crystals

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

200

solubility

H2O: >10 mg/mL, clear

solubility

H2O: >10 mg/mL

solubility

H2O: >10 mg/mL

solubility

H2O: 1 M at 20 °C, clear, colorless

storage condition

desiccated

storage condition

desiccated

storage condition

protect from light, desiccated

storage condition

-

originator

Sanofi Aventis

originator

-

originator

-

originator

-


Storage Class

11 - Combustible Solids

WGK

WGK 3

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library




Questions

Reviews

No rating value

Active Filters